找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Clinical Ophthalmic Oncology; Retinoblastoma Arun D. Singh,A. Linn Murphree,Bertil E. Damato Book 2015Latest edition Springer-Verlag Berlin

[复制链接]
楼主: 赞美
发表于 2025-3-23 11:17:06 | 显示全部楼层
发表于 2025-3-23 17:38:02 | 显示全部楼层
发表于 2025-3-23 18:55:34 | 显示全部楼层
Informationstechnik und Datenverarbeitungthere is only one gene, ., involved. The fact that almost all patients with bilateral retinoblastoma have a germline mutation in . reinforces that perception. However, for those with unilateral retinoblastoma, genetic counseling is less straightforward as only about 15–20 % will have a germline muta
发表于 2025-3-24 00:01:17 | 显示全部楼层
发表于 2025-3-24 05:11:59 | 显示全部楼层
Nicholas Weininger,Darren Coferherapy. They can be used as primary treatment for small tumors or in conjunction with intravenous chemotherapy for larger tumors (i.e., chemoreduction). Focal therapies have the inherent advantage of eradicating focal areas of tumor formation in the retina without any risk of regional or systemic si
发表于 2025-3-24 08:16:47 | 显示全部楼层
发表于 2025-3-24 14:00:57 | 显示全部楼层
发表于 2025-3-24 15:28:16 | 显示全部楼层
https://doi.org/10.1007/3-211-38090-6nal Classification of Retinoblastoma [1]. The presence of vitreous seeds has long been recognized as a major risk factor for eye survival. Reese [2] already noted that the prognosis of eyes with vitreous seeding at presentation was “very unfavorable” and classified them in the worst eye group (Vb).
发表于 2025-3-24 22:17:32 | 显示全部楼层
发表于 2025-3-24 23:19:14 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-4 21:12
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表